The heart valve devices market reached $10 billion in 2021 and is expected to grow at a CAGR of 13.5% during the forecast period of 2022 to 2030. Implantation of heart valve devices is one of the most common operations used for the treatment of a blockage in the heart valves, which is why these devices are utilized in the first place. Mechanical heart valves, biological heart valves, and transcatheter heart valves are the three primary types of structural heart valve technology that are now available on the market. As a result of an increase in the number of heart valve surgeries performed all over the world, it is anticipated that the global market for heart valve devices would expand at a rate that is consistent with growth during the period covered by the forecast. The expansion of the global market for heart valve devices is anticipated to be driven by technological advances in structural heart devices and procedures. These advancements include aortic valve replacement valves, left arterial closure devices, and tissue or biological valves. However, patients are less likely to have surgery as a result of rising expenses associated with minimally invasive procedures. This, in turn, has a negative impact on the expansion of the global market for heart valve devices. The effectiveness, reproducibility, adaptability, and level of the technical complexity of the product should be the primary concerns of the manufacturers of heart valve devices. Companies operating in the global market for heart valve devices should prioritize the research and development of heart valves made from synthetic material in order to improve their durability, achieve a mechanical function that is comparable to that of native valves, and decrease their reliance on anticoagulant and antithrombotic treatment.
The expansion of various facets of the medical industry as well as medical research in more developed nations is a driver of the growth of medical tourism, which, in turn, will be the foundation for the expansion of the market for heart valve devices. The need for procedures that are only somewhat invasive to address cardiac irregularities has significantly increased. Current automation in heart valve procedures, such as the Transcatheter Aortic Valve Replacement (TAVR), has made way for rising options for surgeries that are functionally identical to one another. It is anticipated that expanding life assurances would ultimately result in a higher proportion of an older population, which will also fuel the expansion of the heart valve market. During the period of time covered by the projection, transcatheter heart valve devices have a robust growth trajectory. It is anticipated that the initiatives launched by a number of government businesses to increase understanding of heart valve replacement surgeries would also contribute to the expansion of the heart valve market. The ever increasing demand for minimally invasive procedures has encouraged players to make significant investments in the research and development of innovative surgical methods. The introduction of new transcatheter heart valve prostheses, such as the SAPIEN Transcatheter Heart Valve, Magna Ease Aortic and Mitral Valves, and PERIMOUNT Aortic/Mitral Valves, is expected to boost the market for transcatheter valves during the forecast period.
As a result of their contribution to revenue, biological heart valves are expected to achieve the position of second-largest market share, resulting in their acquisition of roughly one-third of the market for heart valve devices worldwide. A rise in the number of patients under the age of 60 who are candidates for biological heart valve grafts is driving up demand for the product. It is projected that the elimination of the need for anti-coagulant medications and measures to prevent the formation of blood clots will contribute to the expansion of the market for biological heart valves. The biological heart valves are expected to grow at a CAGR of 9.5% during the forecast period.
It is anticipated that mechanical heart devices would gain the greatest share of the market in terms of volume, thanks to improvements in life expectancy as well as more competitive pricing. The market for heart valve devices in Asia-Pacific is anticipated to increase vigorously at a CAGR of 15% during the forecast period. Because there is a greater number of people suffering from cardiovascular disorders in developing countries, companies that make mechanical heart valve devices are investigating the unrealized market potential in these countries. The infrastructure of the healthcare systems in numerous Asian countries is undergoing rapid improvement. To be able to offer their constituents superior care, governmental entities are placing a primary emphasis on the expansion of their healthcare infrastructure. This element contributes, albeit in a roundabout way, to the acceleration of the growth rate of the market for heart valve devices.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
This product will be delivered within 2 business days.
The expansion of various facets of the medical industry as well as medical research in more developed nations is a driver of the growth of medical tourism, which, in turn, will be the foundation for the expansion of the market for heart valve devices. The need for procedures that are only somewhat invasive to address cardiac irregularities has significantly increased. Current automation in heart valve procedures, such as the Transcatheter Aortic Valve Replacement (TAVR), has made way for rising options for surgeries that are functionally identical to one another. It is anticipated that expanding life assurances would ultimately result in a higher proportion of an older population, which will also fuel the expansion of the heart valve market. During the period of time covered by the projection, transcatheter heart valve devices have a robust growth trajectory. It is anticipated that the initiatives launched by a number of government businesses to increase understanding of heart valve replacement surgeries would also contribute to the expansion of the heart valve market. The ever increasing demand for minimally invasive procedures has encouraged players to make significant investments in the research and development of innovative surgical methods. The introduction of new transcatheter heart valve prostheses, such as the SAPIEN Transcatheter Heart Valve, Magna Ease Aortic and Mitral Valves, and PERIMOUNT Aortic/Mitral Valves, is expected to boost the market for transcatheter valves during the forecast period.
Increasing Product Approvals to Drive the Market Revenues
The incidence of cardiovascular disease is raised when both hypertension and diabetes are present at the same time. Because of socioeconomic variables such as lifestyle-induced food, physical inactivity, and other habits such as smoking, the prevalence of these disorders is on the rise. The demand for heart valve devices is growing as a result of the increasing prevalence of cardiovascular disorders as well as the regulatory approvals being granted for new and more advanced prosthetic heart valves. The Nemours Foundation reports that approximately 1 in every 100 newborns has congenital cardiac abnormality, the severity of which can range from minor to severe. In addition, a study conducted by Micro Interventional Devices, Inc. found that structural heart problems impact around 60 million people in the United States, which is equivalent to approximately 20% -25% of the adult population.Technological Advances in Heart Valve Devices to Increase Market Growth
It is anticipated that the launch of innovative products suitable for use in less invasive procedures will drive growth in the global market for heart valve devices. The market for heart valve devices has already been significantly impacted by tissue valves. The procedures used in today's next-generation heart valve replacements include lower delivery profiles, more controlled placement, improved valve function, reduced paravalvular regurgitation, increased durability, and a lower overall cost. Product innovation has enhanced the growth potential for market players in the heart valve device industry since it makes it possible to treat a broader patient population while simultaneously obtaining greater clinical outcomes. Even though there has been substantial development in the field over the past several years, interventional structural heart treatment is still in the early stages of the market and has a great deal of untapped potential. These devices will continue to be at the forefront of interventional product innovation for a number of years to come as a result of their clever design, new technologies, and novel applications of biomaterials. This is guaranteed by the fact that the boundaries of new product development are constantly being pushed further. In the heart valve devices market, design innovations are assisting market participants in capitalizing on the attractive growth potential.Increasing Prevalence of Cardiac Diseases and Causes Leading to It Remains as the Key Contributing Factor
The ever-increasing proportion of elderly people in the population is having a significant impact on the evolution of the market. The elderly population in the United States is expected to more than double by the year 2050, rising from 43.1 million in 2012 to 83.7 million. Aortic stenosis affects roughly 12.4% of the population in the United States, which is equivalent to around 2.5 million people over the age of 75 in the United States suffering from aortic stenosis, according to data provided by Edwards Lifesciences Corporation. Therefore, the broadening base of the elderly population in the United States, along with the high reimbursement rates, is projected to result in a greatly increased demand for replacement surgery in that country. The unstable lifestyle, lifestyle diseases, the growing population of smokers, and the growing elderly population, as well as the increasing focus on the quality of healthcare and the rapid progress of healthcare reimbursement, are a few of the major factors that will boost the growth of the heart valves market over the forecast period. Other factors that will boost the growth of the market include the rapid progress of healthcare reimbursement.The Increasing Life Expectancy Factor Remains the Motivating Factor
Some of the primary factors that are expected to drive the growth of the heart valves devices market include technological advancements, an increasing geriatric population, an upsurge in the prevalence of heart valve disorders (mitral regurgitation and aortic stenosis), the growth of innovative repair equipment, and an increase in demand for minimally invasive techniques. In addition, a number of nations have increased their spending on healthcare, with the intention of improving the infrastructure and facilities available for medical care in line with the increased funding. Therefore, increasing healthcare costs and an increasing number of heart surgeries, regarding the diagnosis and availability of treatments for heart valve disorders, are likely to boost demand for prosthetic heart valves. These factors are related to the availability of treatments for heart valve disorders.Cost to Remain as the Key Constraint
Despite this, the expansion of the heart valve market is hindered by the high cost of surgical procedures and the stringent administrative requirements of the government. It is anticipated that growth in the spending of key players on research and development activities related to heart devices, as well as an increase in the demand for quick and long-lasting processes among the elderly population, will create advantageous opportunities for players in the heart valve devices market.High Risks Associated with Heart Valve Replacement Surgeries to Limit the Market Size
Because it is an intrusive treatment, heart valve replacement is connected with the possibility of danger, which is a major element that acts as a barrier to the expansion of the cardiac valve market. The replacement operation comes with a number of potential risks, some of which include excessive bleeding, arrhythmia, kidney problems, stroke, heart failure, blood clots, infection, and other potential health issues. The cost of minimally invasive surgery is significantly more than the cost of invasive surgery, despite the fact that minimally invasive methods are accessible with fewer risks and problems. These complications have the potential to dramatically impact the patient pool that is undergoing surgery, which will in turn limit the size of the market.Transcatheter Aortic Valve to Dominate the Market:
In terms of product type, it is anticipated that the transcatheter aortic valve segment is expected to lead the global market during the forecast period of 2022 to 2030. This can be linked to an increase in the number of transcatheter aortic valve replacement surgeries due to the surge in the patient population, the ease of implantation, the high frequency of heart valve illnesses, and the growth in the number of transcatheter heart valve surgery centers. It is anticipated that the market for transcatheter aortic valves would experience significant expansion throughout the course of the period under consideration. It is anticipated that the segment will be driven by the operations of a number of government corporations aimed at increasing understanding regarding heart valve replacement surgery. Players have been motivated to invest in the research and development of novel surgical processes as a result of an increase in the demand for minimally invasive procedures. It is projected that the introduction of new transcatheter heart valves prosthesis products, such as the SAPIEN Transcatheter Heart Valve, Magna Ease Aortic and Mitral Valves, and PERIMOUNT Aortic/Mitral Valves, will drive demand for transcatheter valves.As a result of their contribution to revenue, biological heart valves are expected to achieve the position of second-largest market share, resulting in their acquisition of roughly one-third of the market for heart valve devices worldwide. A rise in the number of patients under the age of 60 who are candidates for biological heart valve grafts is driving up demand for the product. It is projected that the elimination of the need for anti-coagulant medications and measures to prevent the formation of blood clots will contribute to the expansion of the market for biological heart valves. The biological heart valves are expected to grow at a CAGR of 9.5% during the forecast period.
Hospitals Dominate the End Users Market
Hospitals, specialty clinics, and other types of medical facilities are the end users as segmented in the report. The expansion of the hospital segment can be attributed to a number of primary factors, the most important of which are an increasing number of procedures performed in hospitals, favorable health reimbursement, and improving government guidelines for the management of vulvar diseases. It is expected that the specialty clinics and other segments will experience a higher rate of growth as a result of the rising number of private practitioners and the unmet demands of patients.North America Remains the Global Leader with the U.S. Being the Dominant Region
In terms of volume, the North American region owned the greatest share of the global market in 2021, accounting for 45% of the total. The region leads the global market for heart valve devices in terms of the adoption of technologically superior products and techniques, as well as the relatively higher average selling prices of heart valve devices in the region. Additionally, the region leads the market in terms of the number of people who live there. It is anticipated that the United States will maintain its position as the dominant player in the global market for heart valve devices, currently accounting for more than a quarter of the market share. The number of people suffering from heart disease is rising at a breakneck speed all over the world. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death on a global scale. Devices that control the heart valves are required in order to put a stop to the snowballing of cases. According to the survey conducted by the Centers for Disease Control and Prevention (CDC), heart disease is the leading cause of mortality in the United States. The increasing adoption of technologically improved heart valve repair devices in order to shorten the time of treatment and the number of surgeries is likely to be the driving force for market expansion. Additionally, an increase in the number of transcatheter aortic valves approved by the FDA is leading to an increase in the revenue shares of key market participants, which in turn is growing the market for heart valve devices as a whole. Fact. The market for heart valve devices in the United States is expected to grow at a compound annual growth rate (CAGR) of 14% during the forecast period.APAC Remains as the Second Largest and Fastest Growing Geographic Segment
The Asia-Pacific region is in second place, immediately behind the North American continent, and it demonstrates advantageous possibilities for expansion. Key growth factors include substantial investments made by industry participants as well as improvements in healthcare infrastructure.It is anticipated that mechanical heart devices would gain the greatest share of the market in terms of volume, thanks to improvements in life expectancy as well as more competitive pricing. The market for heart valve devices in Asia-Pacific is anticipated to increase vigorously at a CAGR of 15% during the forecast period. Because there is a greater number of people suffering from cardiovascular disorders in developing countries, companies that make mechanical heart valve devices are investigating the unrealized market potential in these countries. The infrastructure of the healthcare systems in numerous Asian countries is undergoing rapid improvement. To be able to offer their constituents superior care, governmental entities are placing a primary emphasis on the expansion of their healthcare infrastructure. This element contributes, albeit in a roundabout way, to the acceleration of the growth rate of the market for heart valve devices.
Heart Valve Devices Remains Concentrated
The global market for heart valve devices is highly concentrated, with only a handful of large firms holding the majority of the market share. The creation of products that are less harmful to the environment is the primary motivation for a number of businesses' large investments in research and development. Edwards Lifesciences retained the largest share, which may be ascribed to the company's varied product portfolio as well as the growing demand for the SAPIEN series of valves that they produce. The company's primary focus is on the research and development of innovative products that are optimized to meet the needs of patients. It is anticipated that this will improve the company's standing in the target market as a whole. On the other hand, Abbott is currently in second place in the market, having entered the industry with the purchase of St. Jude Medical, Inc. Because of the growing investments in research, Abbott is projected to strengthen its position in the market, which will result in an increase in the revenue generated by the heart valves industry. The primary strategies that the leading players have implemented include diversifying their product portfolios and engaging in mergers and acquisitions. Abbott, Boston Scientific Corporation, CryoLife, Inc., Edward Lifesciences Corporation, JenaValve Technology, Inc., Medtronic, Inc., SYMETIS., Neovasc, Inc., Sorin Group (LivaNova plc), Micro Interventional Devices, Inc., XELTIS, TTK HealthCare, and Lepu Medical are some of the key market players that operate in the global heart valve devices market. Other market players include Lepu Medical.Historical & Forecast Period
This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Heart Valve Devices market are as follows:- Research and development budgets of manufacturers and government spending
- Revenues of key companies in the market segment
- Number of end users and consumption volume, price and value.
- Geographical revenues generate by countries considered in the report
- Micro and macro environment factors that are currently influencing the Heart Valve Devices market and their expected impact during the forecast period.
Market Segmentation
Type
- Mechanical Heart Valves
- Aortic Valve
- Mitral Valve
- Biological Heart Valve
- Aortic Valve
- Mitral Valve
- Pulmonary Valve
- Tricuspid Valve
- Transcatheter Valves
- Aortic Valve
- Mitral Valve
- Pulmonary Valve
Valve Type
- Tissue Valve
- Mechanical Valve
Procedure
- Surgical
- Transcatheter
End User
- Heart Valves in Hospitals
- Heart Valves in Ambulatory Surgical Centers
Key questions answered in this report
- What are the key micro and macro environmental factors that are impacting the growth of Heart Valve Devices market?
- What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
- Estimated forecast and market projections up to 2030.
- Which segment accounts for the fastest CAGR during the forecast period?
- Which market segment holds a larger market share and why?
- Are low and middle-income economies investing in the Heart Valve Devices market?
- Which is the largest regional market for Heart Valve Devices market?
- What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
- Which are the key trends driving Heart Valve Devices market growth?
- Who are the key competitors and what are their key strategies to enhance their market presence in the Heart Valve Devices market worldwide?
This product will be delivered within 2 business days.
Table of Contents
1. Preface1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Heart Valve Devices Market
2.2. Global Heart Valve Devices Market, By Type, 2021 (US$ Million)
2.3. Global Heart Valve Devices Market, By Valve Type, 2021 (US$ Million)
2.4. Global Heart Valve Devices Market, By Procedure, 2021 (US$ Million)
2.5. Global Heart Valve Devices Market, By End User, 2021 (US$ Million)
2.6. Global Heart Valve Devices Market, By Geography, 2021 (US$ Million)
2.7. Impact of Covid 19
2.8. Attractive Investment Proposition by Geography, 2021
2.9. Competitive Analysis
2.9.1. Market Positioning of Key Heart Valve Devices Market Vendors
2.9.2. Strategies Adopted by Heart Valve Devices Market Vendors
2.9.3. Key Industry Strategies
2.9.4. Tier Analysis 2021 Versus 2030
2.10. Key Buying Criteria
2.11. Key Case Reports
2.12. Scenario Analysis
2.12.1. Optimistic estimates and analysis
2.12.2. Realistic estimates and analysis
2.12.3. Pessimistic estimates and analysis
2.13. Market Profiling
2.14. Sales and Marketing Plan
2.15. Top Market Conclusions
2.16. Strategic Recommendations
3. Heart Valve Devices Market: Business Outlook & Market Dynamics
3.1. Introduction
3.2. Global Heart Valve Devices Market Value, 2020 - 2030, (US$ Million)
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.2. Market Restraints
3.3.3. Key Challenges
3.3.4. Key Opportunities
3.4. Impact Analysis of Drivers and Restraints
3.5. See-Saw Analysis
3.6. Porter’s Five Force Model
3.6.1. Supplier Power
3.6.2. Buyer Power
3.6.3. Threat Of Substitutes
3.6.4. Threat Of New Entrants
3.6.5. Competitive Rivalry
3.7. PESTEL Analysis
3.7.1. Political Landscape
3.7.2. Economic Landscape
3.7.3. Technology Landscape
3.7.4. Legal Landscape
3.7.5. Social Landscape
3.8. Heptalysis Analysis
3.9. Critical Investigation of Business Problems Through Five Whys Root Cause Analysis & Relevant Solutions
4. Heart Valve Devices Market: By Type, 2020-2030, USD (Million)
4.1. Market Overview
4.2. Growth & Revenue Analysis: 2021 Versus 2030
4.3. Market Segmentation
4.3.1. Mechanical Heart Valves
4.3.1.1. Aortic Valve
4.3.1.2. Mitral Valve
4.3.2. Biological Heart Valve
4.3.2.1. Aortic Valve
4.3.2.2. Mitral Valve
4.3.2.3. Pulmonary Valve
4.3.2.4. Tricuspid Valve
4.3.3. Transcatheter Valves
4.3.3.1. Aortic Valve
4.3.3.2. Mitral Valve
4.3.3.3. Pulmonary Valve
5. Heart Valve Devices Market: By Valve Type, 2020-2030, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2021 Versus 2030
5.3. Market Segmentation
5.3.1. Tissue Valve
5.3.2. Mechanical Valve
6. Heart Valve Devices Market: By Procedure, 2020-2030, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2021 Versus 2030
6.3. Market Segmentation
6.3.1. Surgical
6.3.2. Transcatheter
7. Heart Valve Devices Market: By End User, 2020-2030, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2021 Versus 2030
7.3. Market Segmentation
7.3.1. Heart Valves in Hospitals
7.3.2. Heart Valves in Ambulatory Surgical Centers8. North America Heart Valve Devices Market, 2020-2030, USD (Million)
8.1. Market Overview
8.2. Heart Valve Devices Market: By Type, 2020-2030, USD (Million)
8.3. Heart Valve Devices Market: By Valve Type, 2020-2030, USD (Million)
8.4. Heart Valve Devices Market: By Procedure, 2020-2030, USD (Million)
8.5. Heart Valve Devices Market: By End User, 2020-2030, USD (Million)
8.6.Heart Valve Devices Market: By Region, 2020-2030, USD (Million)
8.6.1.North America
8.6.1.1. U.S.
8.6.1.1.1. Heart Valve Devices Market: By Type, 2020-2030, USD (Million)
8.6.1.1.2. Heart Valve Devices Market: By Valve Type, 2020-2030, USD (Million)
8.6.1.1.3. Heart Valve Devices Market: By Procedure, 2020-2030, USD (Million)
8.6.1.1.4. Heart Valve Devices Market: By End User, 2020-2030, USD (Million)
8.6.1.2. Canada
8.6.1.2.1. Heart Valve Devices Market: By Type, 2020-2030, USD (Million)
8.6.1.2.2. Heart Valve Devices Market: By Valve Type, 2020-2030, USD (Million)
8.6.1.2.3. Heart Valve Devices Market: By Procedure, 2020-2030, USD (Million)
8.6.1.2.4. Heart Valve Devices Market: By End User, 2020-2030, USD (Million)
8.6.1.3. Rest of North America
8.6.1.3.1. Heart Valve Devices Market: By Type, 2020-2030, USD (Million)
8.6.1.3.2. Heart Valve Devices Market: By Valve Type, 2020-2030, USD (Million)
8.6.1.3.3. Heart Valve Devices Market: By Procedure, 2020-2030, USD (Million)
8.6.1.3.4. Heart Valve Devices Market: By End User, 2020-2030, USD (Million)
9. UK and European Union Heart Valve Devices Market, 2020-2030, USD (Million)
9.1. Market Overview
9.2. Heart Valve Devices Market: By Type, 2020-2030, USD (Million)
9.3. Heart Valve Devices Market: By Valve Type, 2020-2030, USD (Million)
9.4. Heart Valve Devices Market: By Procedure, 2020-2030, USD (Million)
9.5. Heart Valve Devices Market: By End User, 2020-2030, USD (Million)
9.6.Heart Valve Devices Market: By Region, 2020-2030, USD (Million)
9.6.1.UK and European Union
9.6.1.1. UK
9.6.1.1.1. Heart Valve Devices Market: By Type, 2020-2030, USD (Million)
9.6.1.1.2. Heart Valve Devices Market: By Valve Type, 2020-2030, USD (Million)
9.6.1.1.3. Heart Valve Devices Market: By Procedure, 2020-2030, USD (Million)
9.6.1.1.4. Heart Valve Devices Market: By End User, 2020-2030, USD (Million)
9.6.1.2. Germany
9.6.1.2.1. Heart Valve Devices Market: By Type, 2020-2030, USD (Million)
9.6.1.2.2. Heart Valve Devices Market: By Valve Type, 2020-2030, USD (Million)
9.6.1.2.3. Heart Valve Devices Market: By Procedure, 2020-2030, USD (Million)
9.6.1.2.4. Heart Valve Devices Market: By End User, 2020-2030, USD (Million)
9.6.1.3. Spain
9.6.1.3.1. Heart Valve Devices Market: By Type, 2020-2030, USD (Million)
9.6.1.3.2. Heart Valve Devices Market: By Valve Type, 2020-2030, USD (Million)
9.6.1.3.3. Heart Valve Devices Market: By Procedure, 2020-2030, USD (Million)
9.6.1.3.4. Heart Valve Devices Market: By End User, 2020-2030, USD (Million)
9.6.1.4. Italy
9.6.1.4.1. Heart Valve Devices Market: By Type, 2020-2030, USD (Million)
9.6.1.4.2. Heart Valve Devices Market: By Valve Type, 2020-2030, USD (Million)
9.6.1.4.3. Heart Valve Devices Market: By Procedure, 2020-2030, USD (Million)
9.6.1.4.4. Heart Valve Devices Market: By End User, 2020-2030, USD (Million)
9.6.1.5. France
9.6.1.5.1. Heart Valve Devices Market: By Type, 2020-2030, USD (Million)
9.6.1.5.2. Heart Valve Devices Market: By Valve Type, 2020-2030, USD (Million)
9.6.1.5.3. Heart Valve Devices Market: By Procedure, 2020-2030, USD (Million)
9.6.1.5.4. Heart Valve Devices Market: By End User, 2020-2030, USD (Million)
9.6.1.6. Rest of Europe
9.6.1.6.1. Heart Valve Devices Market: By Type, 2020-2030, USD (Million)
9.6.1.6.2. Heart Valve Devices Market: By Valve Type, 2020-2030, USD (Million)
9.6.1.6.3. Heart Valve Devices Market: By Procedure, 2020-2030, USD (Million)
9.6.1.6.4. Heart Valve Devices Market: By End User, 2020-2030, USD (Million)
10. Asia Pacific Heart Valve Devices Market, 2020-2030, USD (Million)
10.1. Market Overview
10.2. Heart Valve Devices Market: By Type, 2020-2030, USD (Million)
10.3. Heart Valve Devices Market: By Valve Type, 2020-2030, USD (Million)
10.4. Heart Valve Devices Market: By Procedure, 2020-2030, USD (Million)
10.5. Heart Valve Devices Market: By End User, 2020-2030, USD (Million)
10.6.Heart Valve Devices Market: By Region, 2020-2030, USD (Million)
10.6.1.Asia Pacific
10.6.1.1. China
10.6.1.1.1. Heart Valve Devices Market: By Type, 2020-2030, USD (Million)
10.6.1.1.2. Heart Valve Devices Market: By Valve Type, 2020-2030, USD (Million)
10.6.1.1.3. Heart Valve Devices Market: By Procedure, 2020-2030, USD (Million)
10.6.1.1.4. Heart Valve Devices Market: By End User, 2020-2030, USD (Million)
10.6.1.2. Japan
10.6.1.2.1. Heart Valve Devices Market: By Type, 2020-2030, USD (Million)
10.6.1.2.2. Heart Valve Devices Market: By Valve Type, 2020-2030, USD (Million)
10.6.1.2.3. Heart Valve Devices Market: By Procedure, 2020-2030, USD (Million)
10.6.1.2.4. Heart Valve Devices Market: By End User, 2020-2030, USD (Million)
10.6.1.3. India
10.6.1.3.1. Heart Valve Devices Market: By Type, 2020-2030, USD (Million)
10.6.1.3.2. Heart Valve Devices Market: By Valve Type, 2020-2030, USD (Million)
10.6.1.3.3. Heart Valve Devices Market: By Procedure, 2020-2030, USD (Million)
10.6.1.3.4. Heart Valve Devices Market: By End User, 2020-2030, USD (Million)
10.6.1.4. Australia
10.6.1.4.1. Heart Valve Devices Market: By Type, 2020-2030, USD (Million)
10.6.1.4.2. Heart Valve Devices Market: By Valve Type, 2020-2030, USD (Million)
10.6.1.4.3. Heart Valve Devices Market: By Procedure, 2020-2030, USD (Million)
10.6.1.4.4. Heart Valve Devices Market: By End User, 2020-2030, USD (Million)
10.6.1.5. South Korea
10.6.1.5.1. Heart Valve Devices Market: By Type, 2020-2030, USD (Million)
10.6.1.5.2. Heart Valve Devices Market: By Valve Type, 2020-2030, USD (Million)
10.6.1.5.3. Heart Valve Devices Market: By Procedure, 2020-2030, USD (Million)
10.6.1.5.4. Heart Valve Devices Market: By End User, 2020-2030, USD (Million)
10.6.1.6. Rest of Asia Pacific
10.6.1.6.1. Heart Valve Devices Market: By Type, 2020-2030, USD (Million)
10.6.1.6.2. Heart Valve Devices Market: By Valve Type, 2020-2030, USD (Million)
10.6.1.6.3. Heart Valve Devices Market: By Procedure, 2020-2030, USD (Million)
10.6.1.6.4. Heart Valve Devices Market: By End User, 2020-2030, USD (Million)
11. Latin America Heart Valve Devices Market, 2020-2030, USD (Million)
11.1. Market Overview
11.2. Heart Valve Devices Market: By Type, 2020-2030, USD (Million)
11.3. Heart Valve Devices Market: By Valve Type, 2020-2030, USD (Million)
11.4. Heart Valve Devices Market: By Procedure, 2020-2030, USD (Million)
11.5. Heart Valve Devices Market: By End User, 2020-2030, USD (Million)
11.6.Heart Valve Devices Market: By Region, 2020-2030, USD (Million)
11.6.1.Latin America
11.6.1.1. Brazil
11.6.1.1.1. Heart Valve Devices Market: By Type, 2020-2030, USD (Million)
11.6.1.1.2. Heart Valve Devices Market: By Valve Type, 2020-2030, USD (Million)
11.6.1.1.3. Heart Valve Devices Market: By Procedure, 2020-2030, USD (Million)
11.6.1.1.4. Heart Valve Devices Market: By End User, 2020-2030, USD (Million)
11.6.1.2. Mexico
11.6.1.2.1. Heart Valve Devices Market: By Type, 2020-2030, USD (Million)
11.6.1.2.2. Heart Valve Devices Market: By Valve Type, 2020-2030, USD (Million)
11.6.1.2.3. Heart Valve Devices Market: By Procedure, 2020-2030, USD (Million)
11.6.1.2.4. Heart Valve Devices Market: By End User, 2020-2030, USD (Million)
11.6.1.3. Rest of Latin America
11.6.1.3.1. Heart Valve Devices Market: By Type, 2020-2030, USD (Million)
11.6.1.3.2. Heart Valve Devices Market: By Valve Type, 2020-2030, USD (Million)
11.6.1.3.3. Heart Valve Devices Market: By Procedure, 2020-2030, USD (Million)
11.6.1.3.4. Heart Valve Devices Market: By End User, 2020-2030, USD (Million)
12. Middle East and Africa Heart Valve Devices Market, 2020-2030, USD (Million)
12.1. Market Overview
12.2. Heart Valve Devices Market: By Type, 2020-2030, USD (Million)
12.3. Heart Valve Devices Market: By Valve Type, 2020-2030, USD (Million)
12.4. Heart Valve Devices Market: By Procedure, 2020-2030, USD (Million)
12.5. Heart Valve Devices Market: By End User, 2020-2030, USD (Million)
12.6.Heart Valve Devices Market: By Region, 2020-2030, USD (Million)
12.6.1.Middle East and Africa
12.6.1.1. GCC
12.6.1.1.1. Heart Valve Devices Market: By Type, 2020-2030, USD (Million)
12.6.1.1.2. Heart Valve Devices Market: By Valve Type, 2020-2030, USD (Million)
12.6.1.1.3. Heart Valve Devices Market: By Procedure, 2020-2030, USD (Million)
12.6.1.1.4. Heart Valve Devices Market: By End User, 2020-2030, USD (Million)
12.6.1.2. Africa
12.6.1.2.1. Heart Valve Devices Market: By Type, 2020-2030, USD (Million)
12.6.1.2.2. Heart Valve Devices Market: By Valve Type, 2020-2030, USD (Million)
12.6.1.2.3. Heart Valve Devices Market: By Procedure, 2020-2030, USD (Million)
12.6.1.2.4. Heart Valve Devices Market: By End User, 2020-2030, USD (Million)
12.6.1.3. Rest of Middle East and Africa
12.6.1.3.1. Heart Valve Devices Market: By Type, 2020-2030, USD (Million)
12.6.1.3.2. Heart Valve Devices Market: By Valve Type, 2020-2030, USD (Million)
12.6.1.3.3. Heart Valve Devices Market: By Procedure, 2020-2030, USD (Million)
12.6.1.3.4. Heart Valve Devices Market: By End User, 2020-2030, USD (Million)
13. Company Profile
13.1. Abbott
13.1.1. Company Overview
13.1.2. Financial Performance
13.1.3. Product Portfolio
13.1.4. Strategic Initiatives
13.2. Boston Scientific Corporation
13.2.1. Company Overview
13.2.2. Financial Performance
13.2.3. Product Portfolio
13.2.4. Strategic Initiatives
13.3. CryoLife, Inc.
13.3.1. Company Overview
13.3.2. Financial Performance
13.3.3. Product Portfolio
13.3.4. Strategic Initiatives
13.4. Edward Lifesciences Corporation
13.4.1. Company Overview
13.4.2. Financial Performance
13.4.3. Product Portfolio
13.4.4. Strategic Initiatives
13.5. JenaValve Technology, Inc.
13.5.1. Company Overview
13.5.2. Financial Performance
13.5.3. Product Portfolio
13.5.4. Strategic Initiatives
13.6. Medtronic, Inc.
13.6.1. Company Overview
13.6.2. Financial Performance
13.6.3. Product Portfolio
13.6.4. Strategic Initiatives
13.7. SYMETIS.
13.7.1. Company Overview
13.7.2. Financial Performance
13.7.3. Product Portfolio
13.7.4. Strategic Initiatives
13.8. Neovasc, Inc.
13.8.1. Company Overview
13.8.2. Financial Performance
13.8.3. Product Portfolio
13.8.4. Strategic Initiatives
13.9. Sorin Group (LivaNova plc)
13.9.1. Company Overview
13.9.2. Financial Performance
13.9.3. Product Portfolio
13.9.4. Strategic Initiatives
13.10. Micro Interventional Devices, Inc.
13.10.1. Company Overview
13.10.2. Financial Performance
13.10.3. Product Portfolio
13.10.4. Strategic Initiatives
13.11. XELTIS
13.11.1. Company Overview
13.11.2. Financial Performance
13.11.3. Product Portfolio
13.11.4. Strategic Initiatives
13.12. TTK HealthCare
13.12.1. Company Overview
13.12.2. Financial Performance
13.12.3. Product Portfolio
13.12.4. Strategic Initiatives
13.13. Lepu Medical
13.13.1. Company Overview
13.13.2. Financial Performance
13.13.3. Product Portfolio
13.13.4. Strategic Initiatives
List of Figures
Figure 1 Global Heart Valve Devices Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Heart Valve Devices Market: Quality Assurance
Figure 5 Global Heart Valve Devices Market, By Type, 2021
Figure 6 Global Heart Valve Devices Market, By Valve Type, 2021
Figure 7 Global Heart Valve Devices Market, By Procedure, 2021
Figure 8 Global Heart Valve Devices Market, By End User, 2021
Figure 9 Global Heart Valve Devices Market, By Geography, 2021
Figure 10 Market Geographical Opportunity Matrix - Global Heart Valve Devices Market, 2021
Figure 11 Market Positioning of Key Heart Valve Devices Market Players, 2021
Figure 12 Global Heart Valve Devices Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
Figure 13 Porters Five Force Model - Current, Midterm and Long Term Perspective
Figure 14 See Saw Analysis
Figure 15 PETEL Analysis
Figure 16 Key Buying Criteria: Current and Long-Term Perspective
Figure 17 Global Heart Valve Devices Market, Scenario Analysis, 2020 to 2030 (US$ Million)
Figure 18 Heptalysis Analysis: Global Heart Valve Devices Market
Figure 19 Five Whys Analysis
Figure 20 Global Heart Valve Devices Market, By Type, 2021 Vs 2030, %
Figure 21 Global Heart Valve Devices Market, By Valve Type, 2021 Vs 2030, %
Figure 22 Global Heart Valve Devices Market, By Procedure, 2021 Vs 2030, %
Figure 23 Global Heart Valve Devices Market, By End User, 2021 Vs 2030, %
Figure 24 U.S. Heart Valve Devices Market (US$ Million), 2020 - 2030
Figure 25 Canada Heart Valve Devices Market (US$ Million), 2020 - 2030
Figure 26 Rest of North America Heart Valve Devices Market (US$ Million), 2020 - 2030
Figure 27 UK Heart Valve Devices Market (US$ Million), 2020 - 2030
Figure 28 Germany Heart Valve Devices Market (US$ Million), 2020 - 2030
Figure 29 Spain Heart Valve Devices Market (US$ Million), 2020 - 2030
Figure 30 Italy Heart Valve Devices Market (US$ Million), 2020 - 2030
Figure 31 France Heart Valve Devices Market (US$ Million), 2020 - 2030
Figure 32 Rest of Europe Heart Valve Devices Market (US$ Million), 2020 - 2030
Figure 33 China Heart Valve Devices Market (US$ Million), 2020 - 2030
Figure 34 Japan Heart Valve Devices Market (US$ Million), 2020 - 2030
Figure 35 India Heart Valve Devices Market (US$ Million), 2020 - 2030
Figure 36 Australia Heart Valve Devices Market (US$ Million), 2020 - 2030
Figure 37 South Korea Heart Valve Devices Market (US$ Million), 2020 - 2030
Figure 38 Rest of Asia Heart Valve Devices Market (US$ Million), 2020 - 2030
Figure 39 Brazil Heart Valve Devices Market (US$ Million), 2020 - 2030
Figure 40 Mexico Heart Valve Devices Market (US$ Million), 2020 - 2030
Figure 41 Rest of Latin America Heart Valve Devices Market (US$ Million), 2020 - 2030
Figure 42 GCC Heart Valve Devices Market (US$ Million), 2020 - 2030
Figure 43 Africa Heart Valve Devices Market (US$ Million), 2020 - 2030
Figure 44 Rest of Middle East and Africa Heart Valve Devices Market (US$ Million), 2020 - 2030
List of Tables
Table 1 Global Heart Valve Devices Market By Type, 2020-2030, USD (Million)
Table 2 Global Heart Valve Devices Market By Mechanical Heart Valves, 2020-2030, USD (Million)
Table 3 Global Heart Valve Devices Market By Biological Heart Valve, 2020-2030, USD (Million)
Table 4 Global Heart Valve Devices Market By Transcatheter Valves, 2020-2030, USD (Million)
Table 5 Global Heart Valve Devices Market By Valve Type, 2020-2030, USD (Million)
Table 6 Global Heart Valve Devices Market By Procedure, 2020-2030, USD (Million)
Table 7 Global Heart Valve Devices Market By End User, 2020-2030, USD (Million)
Table 8 North America Heart Valve Devices Market By Type, 2020-2030, USD (Million)
Table 9 North America Heart Valve Devices Market By Mechanical Heart Valves, 2020-2030, USD (Million)
Table 10 North America Heart Valve Devices Market By Biological Heart Valve, 2020-2030, USD (Million)
Table 11 North America Heart Valve Devices Market By Transcatheter Valves, 2020-2030, USD (Million)
Table 12 North America Heart Valve Devices Market By Valve Type, 2020-2030, USD (Million)
Table 13 North America Heart Valve Devices Market By Procedure, 2020-2030, USD (Million)
Table 14 North America Heart Valve Devices Market By End User, 2020-2030, USD (Million)
Table 15 U.S. Heart Valve Devices Market By Type, 2020-2030, USD (Million)
Table 16 U.S. Heart Valve Devices Market By Mechanical Heart Valves, 2020-2030, USD (Million)
Table 17 U.S. Heart Valve Devices Market By Biological Heart Valve, 2020-2030, USD (Million)
Table 18 U.S. Heart Valve Devices Market By Transcatheter Valves, 2020-2030, USD (Million)
Table 19 U.S. Heart Valve Devices Market By Valve Type, 2020-2030, USD (Million)
Table 20 U.S. Heart Valve Devices Market By Procedure, 2020-2030, USD (Million)
Table 21 U.S. Heart Valve Devices Market By End User, 2020-2030, USD (Million)
Table 22 Canada Heart Valve Devices Market By Type, 2020-2030, USD (Million)
Table 23 Canada Heart Valve Devices Market By Mechanical Heart Valves, 2020-2030, USD (Million)
Table 24 Canada Heart Valve Devices Market By Biological Heart Valve, 2020-2030, USD (Million)
Table 25 Canada Heart Valve Devices Market By Transcatheter Valves, 2020-2030, USD (Million)
Table 26 Canada Heart Valve Devices Market By Valve Type, 2020-2030, USD (Million)
Table 27 Canada Heart Valve Devices Market By Procedure, 2020-2030, USD (Million)
Table 28 Canada Heart Valve Devices Market By End User, 2020-2030, USD (Million)
Table 29 Rest of North America Heart Valve Devices Market By Type, 2020-2030, USD (Million)
Table 30 Rest of North America Heart Valve Devices Market By Mechanical Heart Valves, 2020-2030, USD (Million)
Table 31 Rest of North America Heart Valve Devices Market By Biological Heart Valve, 2020-2030, USD (Million)
Table 32 Rest of North America Heart Valve Devices Market By Transcatheter Valves, 2020-2030, USD (Million)
Table 33 Rest of North America Heart Valve Devices Market By Valve Type, 2020-2030, USD (Million)
Table 34 Rest of North America Heart Valve Devices Market By Procedure, 2020-2030, USD (Million)
Table 35 Rest of North America Heart Valve Devices Market By End User, 2020-2030, USD (Million)
Table 36 UK and European Union Heart Valve Devices Market By Type, 2020-2030, USD (Million)
Table 37 UK and European Union Heart Valve Devices Market By Mechanical Heart Valves, 2020-2030, USD (Million)
Table 38 UK and European Union Heart Valve Devices Market By Biological Heart Valve, 2020-2030, USD (Million)
Table 39 UK and European Union Heart Valve Devices Market By Transcatheter Valves, 2020-2030, USD (Million)
Table 40 UK and European Union Heart Valve Devices Market By Valve Type, 2020-2030, USD (Million)
Table 41 UK and European Union Heart Valve Devices Market By Procedure, 2020-2030, USD (Million)
Table 42 UK and European Union Heart Valve Devices Market By End User, 2020-2030, USD (Million)
Table 43 UK Heart Valve Devices Market By Type, 2020-2030, USD (Million)
Table 44 UK Heart Valve Devices Market By Mechanical Heart Valves, 2020-2030, USD (Million)
Table 45 UK Heart Valve Devices Market By Biological Heart Valve, 2020-2030, USD (Million)
Table 46 UK Heart Valve Devices Market By Transcatheter Valves, 2020-2030, USD (Million)
Table 47 UK Heart Valve Devices Market By Valve Type, 2020-2030, USD (Million)
Table 48 UK Heart Valve Devices Market By Procedure, 2020-2030, USD (Million)
Table 49 UK Heart Valve Devices Market By End User, 2020-2030, USD (Million)
Table 50 Germany Heart Valve Devices Market By Type, 2020-2030, USD (Million)
Table 51 Germany Heart Valve Devices Market By Mechanical Heart Valves, 2020-2030, USD (Million)
Table 52 Germany Heart Valve Devices Market By Biological Heart Valve, 2020-2030, USD (Million)
Table 53 Germany Heart Valve Devices Market By Transcatheter Valves, 2020-2030, USD (Million)
Table 54 Germany Heart Valve Devices Market By Valve Type, 2020-2030, USD (Million)
Table 55 Germany Heart Valve Devices Market By Procedure, 2020-2030, USD (Million)
Table 56 Germany Heart Valve Devices Market By End User, 2020-2030, USD (Million)
Table 57 Spain Heart Valve Devices Market By Type, 2020-2030, USD (Million)
Table 58 Spain Heart Valve Devices Market By Mechanical Heart Valves, 2020-2030, USD (Million)
Table 59 Spain Heart Valve Devices Market By Biological Heart Valve, 2020-2030, USD (Million)
Table 60 Spain Heart Valve Devices Market By Transcatheter Valves, 2020-2030, USD (Million)
Table 61 Spain Heart Valve Devices Market By Valve Type, 2020-2030, USD (Million)
Table 62 Spain Heart Valve Devices Market By Procedure, 2020-2030, USD (Million)
Table 63 Spain Heart Valve Devices Market By End User, 2020-2030, USD (Million)
Table 64 Italy Heart Valve Devices Market By Type, 2020-2030, USD (Million)
Table 65 Italy Heart Valve Devices Market By Mechanical Heart Valves, 2020-2030, USD (Million)
Table 66 Italy Heart Valve Devices Market By Biological Heart Valve, 2020-2030, USD (Million)
Table 67 Italy Heart Valve Devices Market By Transcatheter Valves, 2020-2030, USD (Million)
Table 68 Italy Heart Valve Devices Market By Valve Type, 2020-2030, USD (Million)
Table 69 Italy Heart Valve Devices Market By Procedure, 2020-2030, USD (Million)
Table 70 Italy Heart Valve Devices Market By End User, 2020-2030, USD (Million)
Table 71 France Heart Valve Devices Market By Type, 2020-2030, USD (Million)
Table 72 France Heart Valve Devices Market By Mechanical Heart Valves, 2020-2030, USD (Million)
Table 73 France Heart Valve Devices Market By Biological Heart Valve, 2020-2030, USD (Million)
Table 74 France Heart Valve Devices Market By Transcatheter Valves, 2020-2030, USD (Million)
Table 75 France Heart Valve Devices Market By Valve Type, 2020-2030, USD (Million)
Table 76 France Heart Valve Devices Market By Procedure, 2020-2030, USD (Million)
Table 77 France Heart Valve Devices Market By End User, 2020-2030, USD (Million)
Table 78 Rest of Europe Heart Valve Devices Market By Type, 2020-2030, USD (Million)
Table 79 Rest of Europe Heart Valve Devices Market By Mechanical Heart Valves, 2020-2030, USD (Million)
Table 80 Rest of Europe Heart Valve Devices Market By Biological Heart Valve, 2020-2030, USD (Million)
Table 81 Rest of Europe Heart Valve Devices Market By Transcatheter Valves, 2020-2030, USD (Million)
Table 82 Rest of Europe Heart Valve Devices Market By Valve Type, 2020-2030, USD (Million)
Table 83 Rest of Europe Heart Valve Devices Market By Procedure, 2020-2030, USD (Million)
Table 84 Rest of Europe Heart Valve Devices Market By End User, 2020-2030, USD (Million)
Table 85 Asia Heart Valve Devices Market By Type, 2020-2030, USD (Million)
Table 86 Asia Heart Valve Devices Market By Mechanical Heart Valves, 2020-2030, USD (Million)
Table 87 Asia Heart Valve Devices Market By Biological Heart Valve, 2020-2030, USD (Million)
Table 88 Asia Heart Valve Devices Market By Transcatheter Valves, 2020-2030, USD (Million)
Table 89 Asia Heart Valve Devices Market By Valve Type, 2020-2030, USD (Million)
Table 90 Asia Heart Valve Devices Market By Procedure, 2020-2030, USD (Million)
Table 91 Asia Heart Valve Devices Market By End User, 2020-2030, USD (Million)
Table 92 China Heart Valve Devices Market By Type, 2020-2030, USD (Million)
Table 93 China Heart Valve Devices Market By Mechanical Heart Valves, 2020-2030, USD (Million)
Table 94 China Heart Valve Devices Market By Biological Heart Valve, 2020-2030, USD (Million)
Table 95 China Heart Valve Devices Market By Transcatheter Valves, 2020-2030, USD (Million)
Table 96 China Heart Valve Devices Market By Valve Type, 2020-2030, USD (Million)
Table 97 China Heart Valve Devices Market By Procedure, 2020-2030, USD (Million)
Table 98 China Heart Valve Devices Market By End User, 2020-2030, USD (Million)
Table 99 Japan Heart Valve Devices Market By Type, 2020-2030, USD (Million)
Table 100 Japan Heart Valve Devices Market By Mechanical Heart Valves, 2020-2030, USD (Million)
Table 101 Japan Heart Valve Devices Market By Biological Heart Valve, 2020-2030, USD (Million)
Table 102 Japan Heart Valve Devices Market By Transcatheter Valves, 2020-2030, USD (Million)
Table 103 Japan Heart Valve Devices Market By Valve Type, 2020-2030, USD (Million)
Table 104 Japan Heart Valve Devices Market By Procedure, 2020-2030, USD (Million)
Table 105 Japan Heart Valve Devices Market By End User, 2020-2030, USD (Million)
Table 106 India Heart Valve Devices Market By Type, 2020-2030, USD (Million)
Table 107 India Heart Valve Devices Market By Mechanical Heart Valves, 2020-2030, USD (Million)
Table 108 India Heart Valve Devices Market By Biological Heart Valve, 2020-2030, USD (Million)
Table 109 India Heart Valve Devices Market By Transcatheter Valves, 2020-2030, USD (Million)
Table 110 India Heart Valve Devices Market By Valve Type, 2020-2030, USD (Million)
Table 111 India Heart Valve Devices Market By Procedure, 2020-2030, USD (Million)
Table 112 India Heart Valve Devices Market By End User, 2020-2030, USD (Million)
Table 113 Australia Heart Valve Devices Market By Type, 2020-2030, USD (Million)
Table 114 Australia Heart Valve Devices Market By Mechanical Heart Valves, 2020-2030, USD (Million)
Table 115 Australia Heart Valve Devices Market By Biological Heart Valve, 2020-2030, USD (Million)
Table 116 Australia Heart Valve Devices Market By Transcatheter Valves, 2020-2030, USD (Million)
Table 117 Australia Heart Valve Devices Market By Valve Type, 2020-2030, USD (Million)
Table 118 Australia Heart Valve Devices Market By Procedure, 2020-2030, USD (Million)
Table 119 Australia Heart Valve Devices Market By End User, 2020-2030, USD (Million)
Table 120 South Korea Heart Valve Devices Market By Type, 2020-2030, USD (Million)
Table 121 South Korea Heart Valve Devices Market By Mechanical Heart Valves, 2020-2030, USD (Million)
Table 122 South Korea Heart Valve Devices Market By Biological Heart Valve, 2020-2030, USD (Million)
Table 123 South Korea Heart Valve Devices Market By Transcatheter Valves, 2020-2030, USD (Million)
Table 124 South Korea Heart Valve Devices Market By Valve Type, 2020-2030, USD (Million)
Table 125 South Korea Heart Valve Devices Market By Procedure, 2020-2030, USD (Million)
Table 126 South Korea Heart Valve Devices Market By End User, 2020-2030, USD (Million)
Table 127 Latin America Heart Valve Devices Market By Type, 2020-2030, USD (Million)
Table 128 Latin America Heart Valve Devices Market By Mechanical Heart Valves, 2020-2030, USD (Million)
Table 129 Latin America Heart Valve Devices Market By Biological Heart Valve, 2020-2030, USD (Million)
Table 130 Latin America Heart Valve Devices Market By Transcatheter Valves, 2020-2030, USD (Million)
Table 131 Latin America Heart Valve Devices Market By Valve Type, 2020-2030, USD (Million)
Table 132 Latin America Heart Valve Devices Market By Procedure, 2020-2030, USD (Million)
Table 133 Latin America Heart Valve Devices Market By End User, 2020-2030, USD (Million)
Table 134 Brazil Heart Valve Devices Market By Type, 2020-2030, USD (Million)
Table 135 Brazil Heart Valve Devices Market By Mechanical Heart Valves, 2020-2030, USD (Million)
Table 136 Brazil Heart Valve Devices Market By Biological Heart Valve, 2020-2030, USD (Million)
Table 137 Brazil Heart Valve Devices Market By Transcatheter Valves, 2020-2030, USD (Million)
Table 138 Brazil Heart Valve Devices Market By Valve Type, 2020-2030, USD (Million)
Table 139 Brazil Heart Valve Devices Market By Procedure, 2020-2030, USD (Million)
Table 140 Brazil Heart Valve Devices Market By End User, 2020-2030, USD (Million)
Table 141 Mexico Heart Valve Devices Market By Type, 2020-2030, USD (Million)
Table 142 Mexico Heart Valve Devices Market By Mechanical Heart Valves, 2020-2030, USD (Million)
Table 143 Mexico Heart Valve Devices Market By Biological Heart Valve, 2020-2030, USD (Million)
Table 144 Mexico Heart Valve Devices Market By Transcatheter Valves, 2020-2030, USD (Million)
Table 145 Mexico Heart Valve Devices Market By Valve Type, 2020-2030, USD (Million)
Table 146 Mexico Heart Valve Devices Market By Procedure, 2020-2030, USD (Million)
Table 147 Mexico Heart Valve Devices Market By End User, 2020-2030, USD (Million)
Table 148 Rest of Latin America Heart Valve Devices Market By Type, 2020-2030, USD (Million)
Table 149 Rest of Latin America Heart Valve Devices Market By Mechanical Heart Valves, 2020-2030, USD (Million)
Table 150 Rest of Latin America Heart Valve Devices Market By Biological Heart Valve, 2020-2030, USD (Million)
Table 151 Rest of Latin America Heart Valve Devices Market By Transcatheter Valves, 2020-2030, USD (Million)
Table 152 Rest of Latin America Heart Valve Devices Market By Valve Type, 2020-2030, USD (Million)
Table 153 Rest of Latin America Heart Valve Devices Market By Procedure, 2020-2030, USD (Million)
Table 154 Rest of Latin America Heart Valve Devices Market By End User, 2020-2030, USD (Million)
Table 155 Middle East and Africa Heart Valve Devices Market By Type, 2020-2030, USD (Million)
Table 156 Middle East and Africa Heart Valve Devices Market By Mechanical Heart Valves, 2020-2030, USD (Million)
Table 157 Middle East and Africa Heart Valve Devices Market By Biological Heart Valve, 2020-2030, USD (Million)
Table 158 Middle East and Africa Heart Valve Devices Market By Transcatheter Valves, 2020-2030, USD (Million)
Table 159 Middle East and Africa Heart Valve Devices Market By Valve Type, 2020-2030, USD (Million)
Table 160 Middle East and Africa Heart Valve Devices Market By Procedure, 2020-2030, USD (Million)
Table 161 Middle East and Africa Heart Valve Devices Market By End User, 2020-2030, USD (Million)
Table 162 GCC Heart Valve Devices Market By Type, 2020-2030, USD (Million)
Table 163 GCC Heart Valve Devices Market By Mechanical Heart Valves, 2020-2030, USD (Million)
Table 164 GCC Heart Valve Devices Market By Biological Heart Valve, 2020-2030, USD (Million)
Table 165 GCC Heart Valve Devices Market By Transcatheter Valves, 2020-2030, USD (Million)
Table 166 GCC Heart Valve Devices Market By Valve Type, 2020-2030, USD (Million)
Table 167 GCC Heart Valve Devices Market By Procedure, 2020-2030, USD (Million)
Table 168 GCC Heart Valve Devices Market By End User, 2020-2030, USD (Million)
Table 169 Africa Heart Valve Devices Market By Type, 2020-2030, USD (Million)
Table 170 Africa Heart Valve Devices Market By Mechanical Heart Valves, 2020-2030, USD (Million)
Table 171 Africa Heart Valve Devices Market By Biological Heart Valve, 2020-2030, USD (Million)
Table 172 Africa Heart Valve Devices Market By Transcatheter Valves, 2020-2030, USD (Million)
Table 173 Africa Heart Valve Devices Market By Valve Type, 2020-2030, USD (Million)
Table 174 Africa Heart Valve Devices Market By Procedure, 2020-2030, USD (Million)
Table 175 Africa Heart Valve Devices Market By End User, 2020-2030, USD (Million)
Table 176 Rest of Middle East and Africa Heart Valve Devices Market By Type, 2020-2030, USD (Million)
Table 177 Rest of Middle East and Africa Heart Valve Devices Market By Mechanical Heart Valves, 2020-2030, USD (Million)
Table 178 Rest of Middle East and Africa Heart Valve Devices Market By Biological Heart Valve, 2020-2030, USD (Million)
Table 179 Rest of Middle East and Africa Heart Valve Devices Market By Transcatheter Valves, 2020-2030, USD (Million)
Table 180 Rest of Middle East and Africa Heart Valve Devices Market By Valve Type, 2020-2030, USD (Million)
Table 181 Rest of Middle East and Africa Heart Valve Devices Market By Procedure, 2020-2030, USD (Million)
Table 182 Rest of Middle East and Africa Heart Valve Devices Market By End User, 2020-2030, USD (Million)
Companies Mentioned
- Abbott
- Boston Scientific Corporation
- CryoLife Inc.
- Edward Lifesciences Corporation
- JenaValve Technology Inc.
- Medtronic Inc.
- SYMETIS.
- Neovasc Inc.
- Sorin Group (LivaNova plc)
- Micro Interventional Devices Inc.
- XELTIS
- TTK HealthCare
- Lepu Medical.
